council-of-scientific-and-industrial-research-csir-india-s-70-year-old-innovation-engine

CSIR is fueling Indian life science since 70 years

  • India
  • |
  • Analysis
  • |
  • By Rahul Koul
  • |
  • 0 Comment

The Bangalore declaration of Council of Scientific and Industrial Research (CSIR) director's meeting, held during the year 1998, concluded that, "India matters to... Read more

what-they-are-saying-about-india-csir1

What are India’s most eminent life science individuals...

  • India
  • |
  • Analysis
  • |
  • By Rahul Koul
  • |
  • 0 Comment

India's Council of Scientific and Industrial Research (CSIR), which was established in 1942 as an autonomous society and with 37 state-of-the-art institutes by Dr... Read more

dr-samir-k-brahmachari-director-general-csir-and-secretary-department-of-scientific-and-industrial-research-dsir

Dr Samir Brahmachari: India’s regulatory infrastructure...

  • India
  • |
  • Influencers
  • |
  • By Rahul Koul
  • |
  • 0 Comment

India's Council of Scientific and Industrial Research (CSIR) celebrated 70 years of existence this year. An organization that was established in 1942 as an autonomous... Read more

gandhi-has-plenty-to-smile-about-government-of-india-is-seriously-investing-in-bio-science

Public funding zooms past $650 mn for Indian life science...

  • India
  • |
  • Analysis
  • |
  • By Rahul Koul
  • |
  • 1 Comment

The Government of India has named 2010-20 as the ‘decade of innovations' and is currently in the process of formulating a new science, technology and innovation... Read more

india-taking-steps-to-curb-fake-drugs

India to develop blueprint to curb fake drugs

New Delhi: Imagine if you come to know that the pill you just popped down to get relief from a bad ailment is a fake. The first reaction would be fear followed,... Read more

industry-academia-meet-focuses-on-innovation-in-india

Industry-academia meet focuses on innovation in India

New Delhi: India's department of biotechnology (DBT) and biotechnology industry research assistance council (BIRAC) have for the first time ever held a meeting called... Read more

us-investors-attracted-to-the-usd74-billion-potential-indian-market

US investors attracted to $74 bn Indian market

New Delhi: Opening a new chapter in the ever-continuing Indo-US cooperative programmes, the Association of Biotechnology Led Enterprises (ABLE) and the US-based... Read more

india-adopts-anti-gm-stand

Indian Parliamentary committee: Ban all GM crop trials

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

August 9, 2012 proved to be a day of setback for GM crops in India with two game changing developments concerning GM technology being announced. The first and the... Read more

sahil-kapoor-novo-informatics

Novo Informatics weaves magic of computational biology

  • India
  • |
  • Influencers
  • |
  • By Rahul Koul
  • |
  • 0 Comment

Drug pricing pressures, stricter regulatory environments and the economic downturn are all pushing the global pharmaceutical sector to look for better ways to develop... Read more

international-aids-symposium-held-in-new-delhi

India gears up to tame the AIDS monster

New Delhi: The 'International Symposium on Accelerating India's Response to Research for a Preventive HIV Vaccine', which was held in New Delhi this week saw a large... Read more

malaria-drug-resistance

Drug resistance keeps malaria threat alive in India

  • India
  • |
  • Analysis
  • |
  • By Rahul Koul
  • |
  • 0 Comment

The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 percent, says a report by ORG IMS in Nov 2011.... Read more

India to focus on diagnostics

India to focus on diagnostics

New Delhi: Despite tremendous opportunities in the disease screening, the areas such as personalized diagnostics have not seen much effort. Dr M K Bhan, secretary,... Read more

What ails India vaccine manufacturing

What ails vaccine manufacturing in India?

  • India
  • |
  • Analysis
  • |
  • By Rahul Koul
  • |
  • 0 Comment

After the India government suspended the licenses of three private sector units on January 15, 2008, it drew a lot of flak from various parliamentary standing committees... Read more

India must leverage on its private strength

India must leverage on its private strength

  • India
  • |
  • Analysis
  • |
  • By Rahul Koul
  • |
  • 0 Comment

India recently decided to revive three of its public sector vaccine manufacturing units and a strong argument in support of their revival is that they will act as... Read more

India revives vaccine PSUs

India revives public sector units in vaccines

  • India
  • |
  • Analysis
  • |
  • By Rahul Koul
  • |
  • 0 Comment

Keeping health security of the country in mind and the success of the Universal Immunization Programme (UIP), India has put its focus back on reviving the public... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X